Centene Corporation ($CNC) Stock Forecast: Down 5.2% Today

What is Centene Corporation?

Centene Corp. (NYSE: CNC) is a health insurance company that offers a variety of programs and services to individuals and families. Today, the stock experienced a strong bearish movement in the market.

Why is Centene Corporation going down?

CNC stock is down 5.2% on Mar 12, 2026 17:25

• A price target cut on Centene Corp. following its fourth-quarter results and concerns about future challenges likely contributed to the bearish movement.
• The overall U.S. HMO industry, including Centene, is facing challenges such as escalating medical costs and regulatory hurdles, despite leveraging technology and M&A for expansion.
• Reducing its stake in UnitedHealth Group may have impacted market sentiment towards health insurance companies like Centene.
• Despite the industry's challenges, Centene and other key HMO companies are positioned for long-term growth, as highlighted by Zacks Equity Research, which could provide some optimism for investors amidst the bearish market movement.

CNC Price Chart

CNC Technical Analysis

CNC News

Bernstein SocGen cuts Centene stock price target on 4Q results

Bernstein SocGen Group lowered its price target for Centene Corp. (NYSE:CNC) to $48 from $59, maintaining an Outperform rating, citing the company's fourth-quarter results and Marketplace enrollment trends. Despite an adjusted diluted loss per share of $1.19 and revenue of $49.73 billion exceeding analyst expectations, concerns about future challenges led to a stock decline. Analyst firms have mixed views, with some raising price targets due to attractive margin opportunities and others lowering them due to concerns about the health insurance exchange business.

https://m.investing.com/news/analyst-ratings/bernstein-socgen-cuts-centene-stock-price-target-on-4q-results-93CH-4557222?ampMode=1

Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana and Centene

The U.S. HMO industry is leveraging technology and M&A for expansion despite challenges like escalating medical costs, regulatory hurdles, and a shortage of healthcare professionals. With anticipated lower borrowing costs, M&A activity is expected to increase. Zacks highlights UnitedHealth Group Inc., The Cigna Group, Humana Inc., and Centene Corp. as four stocks to watch within the industry, positioned to navigate these headwinds.

https://www.theglobeandmail.com/investing/markets/stocks/UNH/pressreleases/706841/zacks-industry-outlook-highlights-unitedhealth-the-cigna-humana-and-centene/

Nemes Rush Group LLC Cuts Stake in UnitedHealth Group Incorporated $UNH

Nemes Rush Group LLC significantly reduced its stake in UnitedHealth Group (NYSE:UNH) by 99.4% in the third quarter, selling 18,975 shares and retaining only 113 shares valued at approximately $39,000. Despite this reduction, UnitedHealth maintains high institutional ownership at 87.86%, with other major investors like Berkshire Hathaway increasing their positions. The company recently reported slightly better-than-expected quarterly earnings, declared a $2.21 quarterly dividend, and holds a "Moderate Buy" consensus rating from Wall Street analysts with an average target price of $372.13.

https://www.marketbeat.com/instant-alerts/filing-nemes-rush-group-llc-cuts-stake-in-unitedhealth-group-incorporated-unh-2026-03-12/

Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana and Centene

The U.S. health insurance industry, specifically Health Maintenance Organizations (HMOs), is experiencing significant changes driven by technological advancements and M&A activities, despite challenges like escalating medical expenses and regulatory hurdles. Zacks Equity Research highlights four key HMO companies—UnitedHealth Group Inc., The Cigna Group, Humana Inc., and Centene Corp.—that are well-positioned to navigate these industry dynamics. Although the overall HMO industry has a bearish outlook based on Zacks Industry Rank, these companies show potential for long-term growth.

https://www.theglobeandmail.com/investing/markets/stocks/CI/pressreleases/706841/zacks-industry-outlook-highlights-unitedhealth-the-cigna-humana-and-centene/

Zacks Industry Outlook Features UnitedHealth, The Cigna, Humana, and Centene

Zacks Equity Research has analyzed the HMO sector, highlighting challenges such as rising healthcare costs and regulatory changes, but noting the resilience of major players like UnitedHealth, Cigna, Humana, and Centene. The industry is seeing digital advancements and M&A activity, though a low Zacks Industry Rank suggests cautious short-term prospects. Despite the overall outlook, four specific HMO stocks are identified as having potential for long-term growth.

https://www.bitget.com/amp/news/detail/12560605259158

Trending Today

LyondellBasell Industries NV Class A (Netherlands) ($LYB) Stock Forecast: Up 9.6% Today

Mettler-Toledo International Inc. ($MTD) Stock Forecast: Down 5.1% Today

Steel Dynamics Inc. ($STLD) Stock Forecast: Down 5.0% Today

Occidental Petroleum Corporation ($OXY) Stock Forecast: Up 5.2% Today

Emerson Electric Company ($EMR) Stock Forecast: Down 5.1% Today

Paysafe Limited ($PSFE) Stock Forecast: Down 5.2% Today

Packaging Corporation of America ($PKG) Stock Forecast: Down 5.2% Today

Cytokinetics, Incorporated ($CYTK) Stock Forecast: Down 5.0% Today

Norwegian Cruise Line Holdings Ltd. ($NCLH) Stock Forecast: Down 5.0% Today

Amcor plc ($AMCR) Stock Forecast: Down 5.1% Today

Centene Corporation Price History

11.02.2026 - CNC Stock was down 7.3%

• Reduction in stake by Capital World Investors in Molina Healthcare (MOH) may have signaled lack of confidence in the healthcare sector, impacting CNC's stock negatively.
• CNC's stock decline can be attributed to warnings of lower membership in Affordable Care Act plans and higher utilization patterns in specialty pharmacy, raising concerns about future revenue streams.
• The market's mixed performance with Centene lagging behind while BridgeBio Pharma led suggests a sector-specific issue affecting CNC rather than broader market conditions.
• Surge in Valero Energy and Baker Hughes stocks, driven by favorable oil prices, highlights a shift towards traditional energy sources, potentially diverting investor attention away from healthcare and renewable energy sectors like CNC and First Solar.

06.01.2026 - CNC Stock was down 8.7%

• Centene's stock faced a bearish movement attributed to a mix of financial results for Q4 and full-year 2025, surpassing revenue expectations.
• A Q4 loss of $1.1 billion and notable decreases in adjusted EBITDA and operating margin influenced the negative market response.
• Despite favorable 2026 guidance and beating profit predictions, concerns arose regarding the conversion of adjusted earnings into sustainable GAAP profitability.
• The market sentiment was influenced by a higher consolidated health benefits ratio, especially in Centene's Commercial segment, outweighing the positive revenue performance.

06.01.2026 - CNC Stock was down 6.1%

• In Q4 CY2025, Centene Corporation exceeded revenue projections, but despite this positive performance, the company experienced a substantial loss for the entire year due to increased medical expenses and reductions in Medicaid funding.
• The reported $6.6 billion loss by Centene, coupled with a goodwill impairment charge, contributed to a downward trend in the stock market.
• Despite a favorable 2026 profit outlook that surpassed expectations on Wall Street, the market responded unfavorably to Centene's mixed financial outcomes for 2025.
• Investors appeared disappointed by the company's challenge in translating adjusted earnings into sustainable GAAP profitability, resulting in a notable decline in the stock's value.

27.00.2026 - CNC Stock was down 7.3%

• Vanguard Personalized Indexing Management LLC and Simplicity Wealth LLC significantly reduced their positions in Elevance Health, Inc. ($ELV) in Q3.
• UnitedHealth Group's promise to return all Obamacare profits in 2026 is seen as a move to pressure competitors like Centene, potentially affecting CNC's market position and profitability.
• Investment House LLC's purchase of shares in Elevance Health demonstrates institutional interest in the healthcare sector, diverting attention from companies like Centene.
• Baird's analysis of UnitedHealth Group's ACA rebate suggests potential challenges for companies like Centene, impacting CNC's market movement today due to reliance on ACA exchange profitability.

27.00.2026 - CNC Stock was down 11.2%

• CNC stock saw a significant drop following the announcement of minimal payment rate increases for Medicare Advantage in 2027 by federal regulators, which was below market expectations. This news had a pronounced impact on Centene due to its heavy reliance on government health programs and complex patient demographics.
• Concerns in the sector were exacerbated by challenges faced by UnitedHealth Group, illustrated by higher medical care ratios and a reduced revenue outlook, further contributing to negative investor sentiment towards healthcare insurers.
• The proposal by the Trump administration to maintain flat Medicare Advantage rates for 2027 directly affected CNC and other insurers, resulting in a sharp decline in stock values due to heightened worries about profitability.
• UnitedHealth Group's decision to repatriate profits from Obamacare in 2026 was viewed as a strategic maneuver to increase pressure on competitors like Centene and Molina, contributing to the overall market volatility in the healthcare industry.

27.00.2026 - CNC Stock was down 10.9%

• Centene (CNC) stock dropped as federal regulators revealed a minimal payment increase for Medicare Advantage in 2027, significantly lower than anticipated by the market.
• Concerns about tighter margins and uncertainty regarding regulations prompted a sector-wide sell-off, particularly affecting companies like Centene heavily involved in government health programs.
• The sudden regulatory shift posed risks for insurers reliant on Medicare Advantage, leading to a steep fall in Centene's stock value.
• The market's response emphasizes the vulnerability of healthcare stocks to regulatory changes and underscores the significance of monitoring governmental policies for potential industry impacts.

29.00.2026 - CNC Stock was up 5.2%

• CNC stock surged despite challenges in the broader healthcare sector due to funding updates for Medicare Advantage in 2027.
• The positive movement might be linked to philanthropic efforts, as WellCare of Kentucky and the Centene Foundation donated $145,000 to food pantries in Kentucky, demonstrating Centene's commitment to community welfare.
• CNC's ability to withstand market pressures suggests investor confidence in its resilience amid regulatory changes.
• While some insurers faced drops, CNC's performance could be driven by investor focus on its upcoming earnings release and future strategic moves.

12.02.2026 - CNC Stock was down 5.2%

• A price target cut on Centene Corp. following its fourth-quarter results and concerns about future challenges likely contributed to the bearish movement.
• The overall U.S. HMO industry, including Centene, is facing challenges such as escalating medical costs and regulatory hurdles, despite leveraging technology and M&A for expansion.
• Reducing its stake in UnitedHealth Group may have impacted market sentiment towards health insurance companies like Centene.
• Despite the industry's challenges, Centene and other key HMO companies are positioned for long-term growth, as highlighted by Zacks Equity Research, which could provide some optimism for investors amidst the bearish market movement.

10.01.2026 - CNC Stock was up 5.4%

• Centene Corporation (CNC) reported a GAAP diluted loss per share of $13.53 for 2025 but showed progress with an adjusted diluted EPS of $2.08 and expects the 2026 adjusted diluted EPS to exceed $3.00. This positive outlook contributed to the bullish movement.
• Institutional investors reducing their stakes in Elevance Health, Inc. (ELV) might have shifted focus towards CNC, driving up its stock price.
• The ongoing investigation into potential fraud involving premium subsidies for Affordable Care Act health insurers could have also influenced investors to favor CNC, a company with promising growth potential and improving earnings power.

10.01.2026 - CNC Stock was up 5.3%

• CNC stock surged due to the positive outlook provided in the company's 2025 results and 2026 guidance, with expectations of exceeding $3.00 in adjusted diluted EPS.
• The market responded favorably to Centene's efforts to restore its earnings power, despite reporting a GAAP diluted loss per share in 2025.
• The bearish movement in Humana stock hitting a 52-week low may have indirectly benefited CNC, as investors potentially shifted focus to Centene's growth potential within the healthcare sector.
• The overall positive sentiment towards CNC was reinforced by Morgan Stanley's "Hold" rating, with a price target of $38.00, indicating confidence in the company's future performance.

10.02.2026 - CNC Stock was down 12.3%

• Today, Centene Corporation (CNC) experienced a strong bearish movement in the market, likely influenced by several factors:
• CNC's participation in the Barclays Global Healthcare Conference may have led to profit-taking by investors, as the reaffirmed guidance may not have met heightened expectations.
• The partial redemption of $1 billion of its notes could have raised concerns about the company's financial position and future growth prospects, leading to a sell-off.
• The overall negative sentiment towards healthcare stocks, as evidenced by the performance of other healthcare companies like Elevance Health, could have also contributed to CNC's bearish movement.
• The reduction in stake by the Swiss National Bank in Elevance Health, a healthcare company, might have signaled broader concerns about the sector, impacting CNC's stock price negatively.

10.02.2026 - CNC Stock was down 8.9%

• Today's bearish movement in CNC stock can be attributed to a combination of factors:
• Concerns over regulatory issues with CMS regarding Medicare Advantage drug plans and an expected decline in Medicare Advantage members affecting future performance.
• A reduction in stake by institutional investors like the Swiss National Bank and Vinva Investment Management Ltd signaling uncertainties in Elevance Health's prospects, impacting CNC due to its association with the healthcare industry.
• Market reacting to the overall uncertainty in the healthcare sector and broader market sentiment, despite Centene Corporation reaffirming its 2026 financial guidance at the conference.
• Analysts' positive long-term outlook on Elevance Health's recovery and Centene's financial performance potentially offering support, though short-term concerns and market dynamics influencing CNC's bearish trend.